The partnership with Finnish medical data sciences services vendor MedEngine will help BC Platforms offer end-to-end services for pharma and health-tech companies.
Qiagen will provide IUO tests for NeoGenomics to verify, set up, and run in clinical trials and in anticipation of regulatory approval.
Telehealth service provider GeneMatters is teaming with Clear Genetics to extend the reach of its genetic counselors for health systems and labs.
Telehealth startup PWNHealth will provide physician oversight services to Sema4's recently launched CarrierChek product, allowing for a nationwide rollout.
The alliance will combine the two firms' technologies and know-how to provide doctors with insights into patients' health status.
Vendors DNAnexus and Saphetor hope to create a seamless platform for genome-based biomarker discovery and interpretation.
The services will couple NEB's reagents and expertise in enzyme development and manufacturing with TTP's Desktop Biology product development and engineering know-how.
The newly announced tie-up wants to alleviate the shortage of bioinformaticists by taking over data management and storage for genomics researchers.
The company will provide its molecular thyroid tests to researchers at Einstein Medical Center of Philadelphia.
GATC Biotech said it selected Bluebee's platform for its service because of its increased automation and flexibility.
Researchers are refining a tool to predict a woman's risk of developing breast cancer, according to the Guardian.
According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.
In PNAS this week: gypsy moth genome sequenced, phylogenomic analysis of Polyneopterans, and more.
CNN reports that people's genes tend to have a greater influence on their risk of developing disease than their environment, but it varies by phenotype.